Identification of Neutralising Pembrolizumab Anti-Drug Antibodies in Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
Sci Rep 2021 Sep 28;11(1)19253, SC Sasson, LE Wilkins, RA Watson, C Jolly, O Brain, P Klenerman, A Olsson-Brown, BP FairfaxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.